ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | -13.3% | 285 | -53.3% | 0.01% | -12.5% |
| Q1 2019 | $15,000 | +15.4% | 610 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $13,000 | +18.2% | 610 | -15.3% | 0.01% | +16.7% |
| Q3 2018 | $11,000 | -8.3% | 720 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $12,000 | 0.0% | 720 | -2.7% | 0.01% | 0.0% |
| Q1 2018 | $12,000 | +33.3% | 740 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $9,000 | -99.9% | 740 | +27.6% | 0.01% | -37.5% |
| Q3 2017 | $13,407,000 | +47.0% | 580 | -46.8% | 0.01% | +33.3% |
| Q2 2017 | $9,123,000 | -1.4% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $9,254,000 | +92440.0% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,000 | +150.0% | 1,090 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $4,000 | +100.0% | 1,090 | +113.7% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |